文献速递类风湿关节炎

症状前个体自身抗体靶向的表位可预测早期类风湿关节炎

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2025-05-09

研究分析源自类风湿关节炎患者的单克隆抗瓜氨酸化蛋白抗体(ACPA)及瑞典520例症状前个体(其中244例在诊断时再次采样)和530例人群对照的血浆,并在690例未经治疗的早期类风湿关节炎患者(NORD-STAR队列)中验证。结果显示,对某些瓜氨酸化ENO1和PAD4肽段的ACPA反应与较低的CRP和DAS28水平相关,且在症状出现前数年即可预测较低的疾病活动度。

要点

  • 症状前阶段对瓜氨酸化肽段的ACPA反应随时间向发病推移而增加。
  • 对ENO1和PAD4肽段的ACPA反应与较低的CRP、DAS28及其组分相关。
  • 在早期类风湿关节炎中,该关联在类风湿因子阴性患者中基于较低的肿胀关节计数更为明显。

核心结论

  • 对某些瓜氨酸化表位的抗体反应与未经治疗的早期类风湿关节炎较低的疾病活动度相关,并在类风湿关节炎症状出现前数年即可出现。

研究设计与样本

  • 分析源自类风湿关节炎患者的单克隆ACPA(包括已表征的保护性ACPA克隆E4),以及瑞典520例症状前个体(其中244例也在类风湿关节炎诊断时采样)和530例人群对照的血浆样本。
  • 验证队列为北欧风湿病策略试验与登记库(NORD-STAR),由690例未经治疗的早期类风湿关节炎患者组成。
  • 通过基于微珠的多重流式免疫分析法分析对瓜氨酸化或天然α-烯醇化酶(ENO1)或肽酰精氨酸脱亚氨酶4(PAD4)肽段的反应。

主要发现

  • 单克隆ACPA对ENO1和PAD4肽段显示出不同的结合模式。
  • 在症状前阶段向发病推移的过程中,观察到对瓜氨酸化肽段的ACPA反应呈时间依赖性增加。
  • 在症状前阶段(发病前0.2-5年)和早期类风湿关节炎阶段,对若干ENO1和PAD4肽段的ACPA反应与较低的CRP水平以及较低的DAS28及其组分水平相关,即与较不严重的类风湿关节炎相关。
  • 在早期类风湿关节炎中,基于较低的肿胀关节计数,该关联在类风湿因子阴性患者中更为明显。
  • 在症状前个体中,ACPA反应广泛预测早期类风湿关节炎较低的疾病活动度,并在5个选定的肽段中更为明显。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine anticitrullinated protein antibody (ACPA) responses to novel peptides predicting the clinical outcomes of treatment-naïve early rheumatoid arthritis (RA) in the presymptomatic stage. METHODS: We analysed monoclonal ACPAs derived from RA patients, including a characterised protective ACPA (clone E4), along with plasma samples collected from 520 presymptomatic individuals, of whom 244 were also sampled at diagnosis of RA, and 530 population controls in Sweden. The validation cohort (The Nordic Rheumatic Diseases Strategy Trials and Registries, NORD-STAR) consisted of 690 treatment-naïve early RA patients. Responses to citrullinated or native alpha-enolase (ENO1) or peptidylarginine deiminase 4 (PAD4) peptides were analysed by bead-based multiplex flow immunoassay. Clinical outcomes included C-reactive protein (CRP) and the 28-joint disease activity score (DAS28) with its components: tender joint count (TJC), swollen joint count (SJC), and erythrocyte sedimentation rate (ESR). RESULTS: Monoclonal ACPAs displayed distinct binding patterns to ENO1 and PAD4 peptides. A time-dependent increase of ACPA response to citrullinated peptides was observed in the presymptomatic stage towards onset. In the presymptomatic (0.2-5 years before onset) and early RA stage, ACPA responses to several ENO1 and PAD4 peptides were associated with less severe RA, assessed as lower levels of CRP and DAS28 and its components. In early RA, the association was more pronounced in rheumatoid factor (RF)-negative patients based on lower SJC. In presymptomatic individuals, ACPA responses widely predicted lower disease activity in early RA and were more pronounced in 5 selected peptides. CONCLUSIONS: Antibody responses to certain citrullinated epitopes are associated with lower disease activity in treatment-naïve early RA and appear years before symptom onset of RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. He Y, Sareila O, Johansson L, et al. Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis. Ann Rheum Dis. 2025. PMID: 40348635. doi:10.1016/j.ard.2025.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。